Claudia Rössig

10.4k total citations · 2 hit papers
157 papers, 5.8k citations indexed

About

Claudia Rössig is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Claudia Rössig has authored 157 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Oncology, 52 papers in Immunology and 35 papers in Molecular Biology. Recurrent topics in Claudia Rössig's work include CAR-T cell therapy research (76 papers), Immune Cell Function and Interaction (35 papers) and Acute Lymphoblastic Leukemia research (23 papers). Claudia Rössig is often cited by papers focused on CAR-T cell therapy research (76 papers), Immune Cell Function and Interaction (35 papers) and Acute Lymphoblastic Leukemia research (23 papers). Claudia Rössig collaborates with scholars based in Germany, United States and France. Claudia Rössig's co-authors include Malcolm K. Brenner, Cliona M. Rooney, Martin Pulé, Gianpietro Dotti, Helen E. Heslop, Bianca Altvater, Barbara Savoldo, Enli Liu, Hao Liu and Gary D. Myers and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Claudia Rössig

154 papers receiving 5.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma

2008 919 citations Martin Pulé, Claudia Rössig et al. profile →
Antitumor activity and long-term fate of chimeric antigen receptor–positive T cells in patients with neuroblastoma

2011 882 citations Gianpietro Dotti, Martin Pulé et al. profile →

Peers

Countries citing papers authored by Claudia Rössig

Since Specialization

Citations

This map shows the geographic impact of Claudia Rössig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudia Rössig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudia Rössig more than expected).

Fields of papers citing papers by Claudia Rössig

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudia Rössig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudia Rössig. The network helps show where Claudia Rössig may publish in the future.

Co-authorship network of co-authors of Claudia Rössig

This figure shows the co-authorship network connecting the top 25 collaborators of Claudia Rössig. A scholar is included among the top collaborators of Claudia Rössig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudia Rössig. Claudia Rössig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Teleangiectatic Osteosarcoma Treated by Surgery and Chemotherapy: A Report of 223 Affected Patients From the Cooperative Osteosarcoma Study Group ( COSS ) 2025 ·Cancer Medicine ·Stefan Bielack, (unknown), Daniel Baumhoer, Andreas Beilken, Claudia Blattmann, Godehard Friedel, Jendrik Hardes, Wolf Hassenpflug, Leo Kager, Matthias Kevric, Thekla von Kalle, Andreas E. Kulozik, Markus Metzler, Michaela Nathrath, Claudia Rössig, Benjamin Sorg, (unknown), Stefanie Hecker‐Nolting	1
2	Protocol for assessing GD2 on formalin-fixed paraffin-embedded tissue sections using immunofluorescence staining 2024 ·STAR Protocols ·Sareetha Kailayangiri, Bianca Altvater, (unknown), Jutta Meltzer, Wolfgang Hartmann, Claudia Rössig	1
3	Osteosarcoma as a secondary malignancy following rhabdomyosarcoma: A report of 28 affected patients from the Cooperative Osteosarcoma Study Group (COSS) 2024 ·Pediatric Blood & Cancer ·Stefan Bielack, (unknown), Stefanie Hecker‐Nolting, Arndt Borkhardt, Jendrik Hardes, Leo Kager, Thekla von Kalle, Matthias Kevric, Ewa Kościelniak, Christian P. Kratz, Thomas Kühne, Michaela Nathrath, Claudia Rössig, Benjamin Sorg, Monika Sparber‐Sauer, Mathias Werner, Claudia Blattmann	1
4	Exploiting WEE1 Kinase Activity as FUS::DDIT3-Dependent Therapeutic Vulnerability in Myxoid Liposarcoma 2024 ·Clinical Cancer Research ·(unknown), Kwang Seok Lee, (unknown), (unknown), (unknown), (unknown), Susanne Häfner, Bianca Altvater, Claudia Rössig, Pierre Åman, Eva Wardelmann, Claudia Scholl, Wolfgang Hartmann, Stefan Fröhling, Marcel Trautmann	1
5	Specific and safe targeting of glioblastoma using switchable and logic-gated RevCAR T cells 2023 ·Frontiers in Immunology ·(unknown), Nicola Mitwasi, Martin Ullrich, Manja Kubeil, Magali Toussaint, Winnie Deuther‐Conrad, Christin Neuber, Claudia Arndt, Liliana R. Loureiro, Alexandra Kegler, (unknown), (unknown), Claudia Rössig, Jens Pietzsch, (unknown), Michael Bachmann, Anja Feldmann	9
6	Parvovirus B19 infection in pediatric allogeneic hematopoietic cell transplantation – Single‐center experience and review 2023 ·Transplant Infectious Disease ·(unknown), (unknown), (unknown), (unknown), Claudia Rössig, Birgit Burkhardt, Andreas H. Groll	8
7	Stopping antibacterial prophylaxis in pediatric allogeneic hematopoietic cell transplantation: An internal audit 2023 ·Transplant Infectious Disease ·(unknown), (unknown), (unknown), (unknown), Frieder Schaumburg, Claudia Rössig, Birgit Burkhardt, Andreas H. Groll	1
8	Cobimetinib in Pediatric and Young Adult Patients with Relapsed or Refractory Solid Tumors (iMATRIX-cobi): A Multicenter, Phase I/II Study 2022 ·Targeted Oncology ·Tanya Trippett, Helen Toledano, Quentin Campbell Hewson, Arnauld Verschuur, Anne‐Marie Langevin, Isabelle Aerts, Lisa Howell, Soledad Gallego, Claudia Rössig, Amy Smith, Darshak Patel, Leonardo Pereira, Sravanthi Cheeti, Luna Musib, Katherine E. Hutchinson, Clare Devlin, Ronald J. Bernardi, Birgit Geoerger	30
9	Titratable Pharmacological Regulation of CAR T Cells Using Zinc Finger-Based Transcription Factors 2021 ·Cancers ·(unknown), (unknown), Winfried Krueger, André Roy, Wa’el Al Rawashdeh, (unknown), (unknown), Brian Webster, (unknown), Dominik Lock, (unknown), Dina Schneider, Stephan Ludwig, Claudia Rössig, Mario Assenmacher, (unknown), Andrew Kaiser	13
10	Invasive Fungal Diseases in Children with Hematological Malignancies Treated with Therapies That Target Cell Surface Antigens: Monoclonal Antibodies, Immune Checkpoint Inhibitors and CAR T-Cell Therapies 2021 ·Journal of Fungi ·Ioannis Kyriakidis, Eleni Vasileiou, Claudia Rössig, Emmanuel Roilides, Andreas H. Groll, Athanasios Tragiannidis	26
11	SIRPα-specific monoclonal antibody enables antibody-dependent phagocytosis of neuroblastoma cells 2021 ·Cancer Immunology Immunotherapy ·(unknown), Sareetha Kailayangiri, (unknown), (unknown), Claudia Rössig, François Paris, Sophie Fougeray, Stéphane Birklé	13
12	Phosphatidylinositol-3-kinase (PI3K)/Akt Signaling is Functionally Essential in Myxoid Liposarcoma 2019 ·Molecular Cancer Therapeutics ·Marcel Trautmann, (unknown), (unknown), (unknown), Arne Krüger, Inga Grünewald, Konrad Steinestel, Bianca Altvater, Claudia Rössig, Susanne Häfner, Thomas Simmet, Jessica Becker, Pierre Åman, Eva Wardelmann, Sebastian Huss, Wolfgang Hartmann	28
13	Epidemiology, utilisation of healthcare resources and outcome of invasive fungal diseases following paediatric allogeneic haematopoietic stem cell transplantation 2019 ·Mycoses ·(unknown), Karoline Ehlert, Martina Ahlmann, Birgit Fröhlich, (unknown), Birgit Burkhardt, Claudia Rössig, Andreas H. Groll	22
14	SS18-SSX–Dependent YAP/TAZ Signaling in Synovial Sarcoma 2019 ·Clinical Cancer Research ·(unknown), (unknown), (unknown), Sareetha Kailayangiri, Bianca Altvater, Claudia Rössig, Konrad Steinestel, Inga Grünewald, Sebastian Huss, Eva Eßeling, Jan‐Henrik Mikesch, Susanne Häfner, Thomas Simmet, Agnieszka Woźniak, Patrick Schöffski, Olle Larsson, Eva Wardelmann, Marcel Trautmann, Wolfgang Hartmann	38
15	Epidemiology and management burden of invasive fungal infections after autologous hematopoietic stem cell transplantation: 10‐year experience at a European Pediatric Cancer Center 2019 ·Mycoses ·(unknown), Athanasios Tragiannidis, Martina Ahlmann, Birgit Fröhlich, (unknown), Birgit Burkhardt, Claudia Rössig, Andreas H. Groll	9
16	Durable control of hepatitis C through interferon‐free antiviral combination therapy immediately prior to allogeneic haematopoietic stem cell transplantation 2018 ·Journal of Viral Hepatitis ·(unknown), (unknown), Stefan Zöllner, (unknown), О. В. Макарова, Thomas Kaiser, Aleksandra Pettke, Claudia Rössig, Birgit Burkhardt, Andreas H. Groll	2
17	FUS–DDIT3 Fusion Protein-Driven IGF-IR Signaling is a Therapeutic Target in Myxoid Liposarcoma 2017 ·Clinical Cancer Research ·Marcel Trautmann, (unknown), (unknown), (unknown), (unknown), Konrad Steinestel, (unknown), Inga Grünewald, Bianca Altvater, Claudia Rössig, Stefan Fröhling, Susanne Häfner, Thomas Simmet, Pierre Åman, Eva Wardelmann, Sebastian Huss, Wolfgang Hartmann	38
18	Vaccination Targeting Native Receptors to Enhance the Function and Proliferation of Chimeric Antigen Receptor (CAR)-Modified T Cells 2017 ·Clinical Cancer Research ·Miyuki Tanaka, Haruko Tashiro, Bilal Omer, (unknown), Jun Ando, Minhtran Ngo, Birju Mehta, Gianpietro Dotti, Paul R. Kinchington, Ann M. Leen, Claudia Rössig, Cliona M. Rooney	81
19	2B4 (CD244) Signaling by Recombinant Antigen-specific Chimeric Receptors Costimulates Natural Killer Cell Activation to Leukemia and Neuroblastoma Cells 2009 ·Clinical Cancer Research ·Bianca Altvater, Silke Landmeier, Sibylle Pscherer, (unknown), (unknown), Sareetha Kailayangiri, Dario Campana, Heribert Juergens, Martin Pulé, Claudia Rössig	165
20	A high proportion of bone marrow T cells with regulatory phenotype (CD4+CD25^hiFoxP3+) in Ewing sarcoma patients is associated with metastatic disease 2009 ·International Journal of Cancer ·Peter Brinkrolf, Silke Landmeier, Bianca Altvater, (unknown), Sibylle Pscherer, Annegret Rosemann, Andreas Ranft, Uta Dirksen, Heribert Juergens, Claudia Rössig	46

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact